Quick answer
Stimulants such as methylphenidate or amphetamines, and wakefulness drugs like modafinil, are sometimes added to antidepressants for persistent fatigue or low energy. Evidence comes mostly from small or open-label studies, with mixed results. They carry risks including misuse and heart effects, and in New York, controlled stimulants require an I-STOP check before prescribing.
If you’re in crisis right now: call or text 988 (Suicide & Crisis Lifeline) or call 911.
Key Takeaways

- Stimulant add-ons are sometimes considered for fatigue and low energy in depression.
- The evidence is mostly from small or open-label studies, and results are mixed.
- Controlled stimulants require an I-STOP check in New York before prescribing.
- They interact dangerously with MAOIs and need careful review of heart health.
What is stimulant augmentation?
Stimulant augmentation is adding a stimulant or wakefulness-promoting drug to an antidepressant, usually to target fatigue, sleepiness or poor concentration that persists. It’s an add-on, not a first-line depression treatment. This guide is part of our series on treatment-resistant depression in New York.
A psychostimulant is a medication that increases alertness and energy, such as methylphenidate or amphetamines; some are Schedule II controlled substances.
What the evidence shows
A clinical review of psychostimulants in adult depression describes evidence drawn largely from case series, chart reviews and open-label trials, with some positive reports and some patients reporting no improvement.4 That’s a reason for cautious, measured use rather than routine use.
What are the risks and rules for stimulant add-ons in New York?
Risks include misuse, sleep problems, raised heart rate and blood pressure, and anxiety. Stimulants interact dangerously with MAOIs.5 In New York, prescribers must consult I-STOP before prescribing Schedule II–IV controlled substances, and prescriptions must be sent electronically.1,2
If fatigue is driven by poor sleep, see insomnia and resistant depression first.
What's checked before a stimulant add-on?
A stimulant add-on is considered only after several questions are answered.
- Is fatigue coming from depression, sleep problems, a medical cause or another medication?
- Has the antidepressant had a full trial?
- Is there a history of substance misuse?
- Are heart health and blood pressure suitable?
- Is an MAOI part of the regimen, now or in the future?
- What does the I-STOP report show?
New York’s I-STOP report shows controlled prescriptions dispensed in the state over the past year.1
What good care looks like
Good care for resistant depression asks why earlier treatment fell short, then chooses the next step on purpose. Here is how that plays out for this situation.
Tired all the time
Mood improves a little, but exhaustion and fog remain, and a stimulant seems like a quick fix.
Find the cause first
Sleep, medical causes and medications are checked before any stimulant is considered.
A cautious, measured trial
If a stimulant is tried, it's monitored closely and stopped if the benefit isn't clear.

Common myths, and what the evidence says
Myth: Stimulants are a well-established add-on for depression.
Fact: Evidence is mostly from small or open-label studies, with mixed results.4
Myth: Stimulants are safe with any antidepressant.
Fact: They interact dangerously with MAOIs.5
Myth: A stimulant is the answer to depression fatigue.
Fact: Fatigue often comes from sleep problems, medical causes or other medications, which should be checked first.
What the first 90 days usually look like
Care moves in steps, and each change is checked before the next one. Your timing may differ, and that’s normal.
Investigate fatigue
Sleep, medical causes, medications and the adequacy of the antidepressant trial are reviewed.
Decide carefully
If a stimulant is considered, risks are weighed and I-STOP is checked.
Monitor closely
A short, measured trial with follow-up; stopped if the benefit isn't clear.

Ready to talk it through with a psychiatrist?
Schedule nowStimulant add-ons for New York patients
Adults who are physically in New York State can be evaluated by secure video. Rules for prescribing controlled medications by telehealth come from federal and state law and can change, so Dr. Farkas will explain what applies at your visit. The practice lists Aetna and Cigna as in-network plans; confirm your plan’s network status for New York care before booking. Self-pay patients receive a superbill and a written good faith estimate.
Questions to ask at your first visit
A clear plan starts with a few direct questions. Bring these with you.
- What's causing my fatigue?
- Is a stimulant reasonable for me?
- What does the evidence show?
- What are the risks for my heart and sleep?
- How would it interact with my other medications?
The bottom line
Stimulant add-ons can help some people with resistant depression, but the evidence is limited and the risks are real. For New York adults, a careful video evaluation starts with finding the cause of fatigue and follows New York's I-STOP rules.
How We Reviewed This Page
This page draws on primary sources including federal agencies (FDA, CDC, HRSA, USPSTF), South Carolina law and state agency notices, ACOG clinical practice guidelines and peer-reviewed research. It was written by Steven Lockhart and is pending clinical review by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist licensed in South Carolina and New York. We review it at least every 180 days or when FDA labeling or clinical guidance changes.
What’s new: September 2026. Page published. Clinical review by Dr. Farkas pending before this page is marked reviewed.
References
- New York State Department of Health. PMP/I-STOP: Prescription Monitoring Program, Internet System for Tracking Over-Prescribing. Accessed September 2026. https://healthweb-back.health.ny.gov/professionals/narcotic/prescription_monitoring/
- New York State Department of Health. Electronic Prescribing: Mandatory Electronic Prescribing Effective March 27, 2016. Accessed September 2026. https://healthweb-back.health.ny.gov/professionals/narcotic/electronic_prescribing/
- U.S. Food and Drug Administration (via Healthcare Purchasing News). FDA Approves New Nasal Spray Medication for Treatment-Resistant Depression. March 7, 2019. https://www.hpnonline.com/home/article/13001954/fda-approves-new-nasal-spray-medication-for-treatment-resistant-depression
- Federal Practitioner (MDedge). A Review of Psychostimulants for Adults With Depression. Accessed September 2026. https://www.mdedge.com/content/review-psychostimulants-adults-depression
- The Carlat Psychiatry Report. MAOIs: Diet, Drug Interactions and Starting a Patient on an MAOI. July/August 2018. https://www.thecarlatreport.com/wp-content/uploads/2018/07/TCPR_July-Aug_2018_MAOIs_Table2.pdf
Frequently Asked Questions
Do stimulants help depression?
Some people with resistant depression report improvement when a stimulant is added, especially for fatigue and low energy. But the evidence comes mostly from small or open-label studies, and results are mixed. That's why stimulants are used cautiously as add-ons rather than as a routine part of depression treatment.
What about modafinil?
Modafinil is a wakefulness-promoting drug sometimes studied as an add-on for depression-related fatigue. Evidence is limited. It has its own side effects and interactions. Your psychiatrist will weigh it against other options, including treating sleep problems directly, before recommending it. Sleep apnea and other causes of daytime sleepiness should be ruled out first.
Do I need an I-STOP check for a stimulant in New York?
Yes. New York prescribers must consult I-STOP before prescribing Schedule II, III or IV controlled substances, which includes most stimulants. The report shows controlled prescriptions dispensed in New York over the past year. It's a routine safety step for every patient. It doesn't mean anyone suspects misuse; it's a standard safety step.
Can I take a stimulant with an MAOI?
Stimulants interact dangerously with MAOIs and can cause a hypertensive crisis. If you take an MAOI, or might in the future, tell your psychiatrist before any stimulant is considered. Always check with your pharmacist before combining medications. The same caution applies to some decongestants and other over-the-counter products that act like stimulants.
Can stimulants be prescribed by telehealth in New York?
Rules for prescribing controlled medications by telehealth come from federal and state law and have changed in recent years. Dr. Farkas will explain what applies to your situation at your visit, including any requirements that must be met first. If a stimulant isn't appropriate by telehealth for you, other options can still be explored by video.
What should I try before a stimulant?
Start by checking whether sleep problems, a medical cause like thyroid disease, or another medication is driving fatigue. Make sure your antidepressant has had a full trial. Treating insomnia directly, often with CBT-I, can improve energy without adding a stimulant. A lab check for thyroid and other medical causes is often part of that first step.



